Literature DB >> 31087362

NaV 1.6 regulates excitability of mechanosensitive sensory neurons.

Mathilde R Israel1, Brian S Tanaka2,3,4, Joel Castro5,6, Panumart Thongyoo1, Samuel D Robinson1, Peng Zhao2,3,4, Jennifer R Deuis1, David J Craik1, Thomas Durek1, Stuart M Brierley5,6, Stephen G Waxman2,3,4, Sulayman D Dib-Hajj2,3,4, Irina Vetter1,7.   

Abstract

KEY POINTS: Voltage-gated sodium channels are critical for peripheral sensory neuron transduction and have been implicated in a number of painful and painless disorders. The β-scorpion toxin, Cn2, is selective for NaV 1.6 in dorsal root ganglion neurons. NaV 1.6 plays an essential role in peripheral sensory neurons, specifically at the distal terminals of mechanosensing fibres innervating the skin and colon. NaV 1.6 activation also leads to enhanced response to mechanical stimulus in vivo. This works highlights the use of toxins in elucidating pain pathways moreover the importance of non-peripherally restricted NaV isoforms in pain generation. ABSTRACT: Peripheral sensory neurons express multiple voltage-gated sodium channels (NaV ) critical for the initiation and propagation of action potentials and transmission of sensory input. Three pore-forming sodium channel isoforms are primarily expressed in the peripheral nervous system (PNS): NaV 1.7, NaV 1.8 and NaV 1.9. These sodium channels have been implicated in painful and painless channelopathies and there has been intense interest in them as potential therapeutic targets in human pain. Emerging evidence suggests NaV 1.6 channels are an important isoform in pain sensing. This study aimed to assess, using pharmacological approaches, the function of NaV 1.6 channels in peripheral sensory neurons. The potent and NaV 1.6 selective β-scorpion toxin Cn2 was used to assess the effect of NaV 1.6 channel activation in the PNS. The multidisciplinary approach included Ca2+ imaging, whole-cell patch-clamp recordings, skin-nerve and gut-nerve preparations and in vivo behavioural assessment of pain. Cn2 facilitates NaV 1.6 early channel opening, and increased persistent and resurgent currents in large-diameter dorsal root ganglion (DRG) neurons. This promotes enhanced excitatory drive and tonic action potential firing in these neurons. In addition, NaV 1.6 channel activation in the skin and gut leads to increased response to mechanical stimuli. Finally, intra-plantar injection of Cn2 causes mechanical but not thermal allodynia. This study confirms selectivity of Cn2 on NaV 1.6 channels in sensory neurons. Activation of NaV 1.6 channels, in terminals of the skin and viscera, leads to profound changes in neuronal responses to mechanical stimuli. In conclusion, sensory neurons expressing NaV 1.6 are important for the transduction of mechanical information in sensory afferents innervating the skin and viscera.
© 2019 The Authors. The Journal of Physiology © 2019 The Physiological Society.

Entities:  

Keywords:  Skin; colon; dorsal root ganglia; ion channels; nociception; pain; patch clamp

Year:  2019        PMID: 31087362     DOI: 10.1113/JP278148

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  11 in total

Review 1.  The physiological function of different voltage-gated sodium channels in pain.

Authors:  George Goodwin; Stephen B McMahon
Journal:  Nat Rev Neurosci       Date:  2021-03-29       Impact factor: 34.870

2.  Australian funnel-web spiders evolved human-lethal δ-hexatoxins for defense against vertebrate predators.

Authors:  Volker Herzig; Kartik Sunagar; David T R Wilson; Sandy S Pineda; Mathilde R Israel; Sebastien Dutertre; Brianna Sollod McFarland; Eivind A B Undheim; Wayne C Hodgson; Paul F Alewood; Richard J Lewis; Frank Bosmans; Irina Vetter; Glenn F King; Bryan G Fry
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-21       Impact factor: 11.205

3.  Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1β release.

Authors:  Hana Starobova; Mercedes Monteleone; Christelle Adolphe; Lena Batoon; Cheyenne J Sandrock; Bryan Tay; Jennifer R Deuis; Alexandra V Smith; Alexander Mueller; Evelyn Israel Nadar; Grace Pamo Lawrence; Amanda Mayor; Elissa Tolson; Jean-Pierre Levesque; Allison R Pettit; Brandon J Wainwright; Kate Schroder; Irina Vetter
Journal:  J Exp Med       Date:  2021-05-03       Impact factor: 14.307

Review 4.  Pain-related toxins in scorpion and spider venoms: a face to face with ion channels.

Authors:  Sylvie Diochot
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2021-12-06

Review 5.  Peripheral Voltage-Gated Cation Channels in Neuropathic Pain and Their Potential as Therapeutic Targets.

Authors:  Sascha R A Alles; Peter A Smith
Journal:  Front Pain Res (Lausanne)       Date:  2021-12-13

Review 6.  The role of mechanosensitive ion channels in the gastrointestinal tract.

Authors:  Haoyu Yang; Chaofeng Hou; Weidong Xiao; Yuan Qiu
Journal:  Front Physiol       Date:  2022-08-19       Impact factor: 4.755

Review 7.  Normalization of Neuroinflammation: A New Strategy for Treatment of Persistent Pain and Memory/Emotional Deficits in Chronic Pain.

Authors:  Xian-Guo Liu
Journal:  J Inflamm Res       Date:  2022-09-09

8.  A novel gain-of-function sodium channel β2 subunit mutation in idiopathic small fiber neuropathy.

Authors:  Matthew Alsaloum; Julie I R Labau; Daniel Sosniak; Peng Zhao; Rowida Almomani; Monique Gerrits; Janneke G J Hoeijmakers; Giuseppe Lauria; Catharina G Faber; Stephen G Waxman; Sulayman Dib-Hajj
Journal:  J Neurophysiol       Date:  2021-07-28       Impact factor: 2.974

9.  Characterization of Synthetic Tf2 as a NaV1.3 Selective Pharmacological Probe.

Authors:  Mathilde R Israel; Thomas S Dash; Stefanie N Bothe; Samuel D Robinson; Jennifer R Deuis; David J Craik; Angelika Lampert; Irina Vetter; Thomas Durek
Journal:  Biomedicines       Date:  2020-06-11

Review 10.  Tetrodotoxin: A New Strategy to Treat Visceral Pain?

Authors:  Ana Campos-Ríos; Lola Rueda-Ruzafa; Salvador Herrera-Pérez; Paula Rivas-Ramírez; José Antonio Lamas
Journal:  Toxins (Basel)       Date:  2021-07-16       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.